Prostatic Adenoma Clinical Trial
— HOLEP-AHCSOfficial title:
Efficacy of Hyaluronic Acid and Chondroitin Sulphate in Intravesical Injections on Functional Recovery After Holmium Laser Surgery for Prostate Adenoma (HOLEP-AHCS)
The purpose of this study is to evaluate the score on urinary function (International Prostate Score Symptom) at 28 days. The main objective is to assess the efficacy of treatment with Ialuril® Prefill on functional recovery at 4 weeks, based on the International Prostate Score Symptom. A paired test will be performed to compare the International Prostate Score Symptom score between 0 and 28 days.
Status | Recruiting |
Enrollment | 34 |
Est. completion date | December 31, 2024 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patient eligible for a HOLEP procedure, according to the investigator ; - Patient able to understand the information related to the clinical investigation, to read the information leaflet and agrees to sign the consent form. Exclusion Criteria: - Known intolerance to one of the treatment components: hyaluronic acid, chondroitin sulphate, calcium chloride; - Prostatic volume greater than 140 cm3; - Patient under anticoagulant treatment for secondary prevention; - Patient under guardianship or curatorship, or under a regime of deprivation of liberty; - Participating patient, or in a period of exclusion from another clinical trial; - Patient not benefiting from a social security scheme. |
Country | Name | City | State |
---|---|---|---|
France | Clinique La Croix du Sud | Quint-Fonsegrives |
Lead Sponsor | Collaborator |
---|---|
GCS Ramsay Santé pour l'Enseignement et la Recherche |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | International Prostate Score Symptom on Day 28 | 28 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02940977 -
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique
|
||
Withdrawn |
NCT05157724 -
Observational Study to Compare Two Prostate Laser Enucleation Techniques in Terms of Urinary Incontinence
|
||
Completed |
NCT04693507 -
Teverelix Evaluated in Advanced Prostate Cancer
|
Phase 2 | |
Completed |
NCT02943070 -
Rezum I Pilot Study for Benign Prostatic Hyperplasia
|
N/A | |
Completed |
NCT02940392 -
Rezum FIM Optimization Study
|
N/A |